Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
PLoS One. 2007 Jun 20;2(6):e550. doi: 10.1371/journal.pone.0000550.
The need for a new surveillance approach to understand the clinical outcomes and behaviors of people in care for HIV evolved from the new challenges for monitoring clinical outcomes in the HAART era, the impact of the epidemic on an increasing number of areas in the US, and the need for representative data to describe the epidemic and related resource utilization and needs. The Institute of Medicine recommended that the Centers for Disease Control and Prevention and the Heath Resources and Services Administration coordinate efforts to survey a random sample of HIV-infected persons in care, in order to more accurately measure the need for prevention and care services. The Medical Monitoring Project (MMP) was created to meet these needs. This manuscript describes the evolution and design of MMP, a new nationally representative clinical outcomes and behavioral surveillance system, and describes how MMP data will be used locally and nationally to identify care and treatment utilization needs, and to plan for prevention interventions and services.
需要一种新的监测方法来了解接受艾滋病毒治疗人群的临床结果和行为,这是因为在高效抗逆转录病毒治疗(HAART)时代,监测临床结果面临新的挑战,艾滋病毒在美国越来越多的地区流行,以及需要有代表性的数据来描述流行情况及相关资源的利用和需求。美国医学研究所建议疾病预防控制中心和卫生资源与服务管理局协调努力,对接受治疗的艾滋病毒感染者进行随机抽样调查,以便更准确地衡量预防和护理服务的需求。医学监测项目(MMP)的创建就是为了满足这些需求。本文描述了 MMP 的演变和设计,MMP 是一个新的具有全国代表性的临床结果和行为监测系统,并描述了 MMP 数据将如何在地方和国家层面用于确定护理和治疗需求,以及规划预防干预措施和服务。